BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 27325481)

  • 1. Validation of High-Risk Computed Tomography Features for Detection of Local Recurrence After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer.
    Peulen H; Mantel F; Guckenberger M; Belderbos J; Werner-Wasik M; Hope A; Giuliani M; Grills I; Sonke JJ
    Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):134-41. PubMed ID: 27325481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can high-risk CT features suggest local recurrence after stereotactic body radiation therapy for lung cancer? A systematic review and meta-analysis.
    Kim TH; Woo S; Halpenny DF; Kim YJ; Yoon SH; Suh CH
    Eur J Radiol; 2020 Jun; 127():108978. PubMed ID: 32298960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-risk CT features for detection of local recurrence after stereotactic ablative radiotherapy for lung cancer.
    Huang K; Senthi S; Palma DA; Spoelstra FO; Warner A; Slotman BJ; Senan S
    Radiother Oncol; 2013 Oct; 109(1):51-7. PubMed ID: 23953413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of High-Risk Radiologic Features in Patients Without Local Recurrence After Stereotactic Ablative Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer.
    Ronden MI; van Sörnsen de Koste JR; Johnson C; Slotman BJ; Spoelstra FOB; Haasbeek CJA; Blom G; Bongers EM; Warner A; Ward A; Palma D; Senan S
    Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):115-121. PubMed ID: 29102278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT imaging features associated with recurrence in non-small cell lung cancer patients after stereotactic body radiotherapy.
    Li Q; Kim J; Balagurunathan Y; Qi J; Liu Y; Latifi K; Moros EG; Schabath MB; Ye Z; Gillies RJ; Dilling TJ
    Radiat Oncol; 2017 Sep; 12(1):158. PubMed ID: 28946909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computed tomographic features predictive of local recurrence in patients with early stage lung cancer treated with stereotactic body radiation therapy.
    Halpenny D; Ridge CA; Hayes S; Zheng J; Moskowitz CS; Rimner A; Ginsberg MS
    Clin Imaging; 2015; 39(2):254-8. PubMed ID: 25571791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computed tomography appearances of local recurrence after stereotactic body radiation therapy for stage I non-small-cell lung carcinoma.
    Kato S; Nambu A; Onishi H; Saito A; Kuriyama K; Komiyama T; Marino K; Araki T
    Jpn J Radiol; 2010 May; 28(4):259-65. PubMed ID: 20512542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation for local failure by 18F-FDG PET/CT in comparison with CT findings after stereotactic body radiotherapy (SBRT) for localized non-small-cell lung cancer.
    Takeda A; Kunieda E; Fujii H; Yokosuka N; Aoki Y; Oooka Y; Oku Y; Ohashi T; Sanuki N; Mizuno T; Ozawa Y
    Lung Cancer; 2013 Mar; 79(3):248-53. PubMed ID: 23246123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography combined with diagnostic chest computed tomography enhances detection of regional recurrence after stereotactic body radiation therapy for early stage non-small cell lung cancer.
    Ebright MI; Russo GA; Gupta A; Subramaniam RM; Fernando HC; Kachnic LA
    J Thorac Cardiovasc Surg; 2013 Mar; 145(3):709-15. PubMed ID: 23317944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Local Cancer Recurrence After Stereotactic Ablative Radiation Therapy for Lung Cancer: Physician Performance Versus Radiomic Assessment.
    Mattonen SA; Palma DA; Johnson C; Louie AV; Landis M; Rodrigues G; Chan I; Etemad-Rezai R; Yeung TP; Senan S; Ward AD
    Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1121-8. PubMed ID: 26907916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal imaging surveillance after stereotactic ablative radiation therapy for early-stage non-small cell lung cancer: Findings of an International Delphi Consensus Study.
    Nguyen TK; Senan S; Bradley JD; Franks K; Giuliani M; Guckenberger M; Landis M; Loo BW; Louie AV; Onishi H; Schmidt H; Timmerman R; Videtic GMM; Palma DA
    Pract Radiat Oncol; 2018; 8(2):e71-e78. PubMed ID: 29291965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of Disease Recurrence after SABR for Early Stage Non-Small-Cell Lung Cancer: Optimizing Follow-Up Schedules for Salvage Therapy.
    Verstegen NE; Lagerwaard FJ; Hashemi SM; Dahele M; Slotman BJ; Senan S
    J Thorac Oncol; 2015 Aug; 10(8):1195-200. PubMed ID: 26200274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography for assessing local failure after stereotactic body radiotherapy for non-small-cell lung cancer.
    Zhang X; Liu H; Balter P; Allen PK; Komaki R; Pan T; Chuang HH; Chang JY
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1558-65. PubMed ID: 22572078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Textural features in pre-treatment [F18]-FDG-PET/CT are correlated with risk of local recurrence and disease-specific survival in early stage NSCLC patients receiving primary stereotactic radiation therapy.
    Pyka T; Bundschuh RA; Andratschke N; Mayer B; Specht HM; Papp L; Zsótér N; Essler M
    Radiat Oncol; 2015 Apr; 10():100. PubMed ID: 25900186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment
    Dissaux G; Visvikis D; Da-Ano R; Pradier O; Chajon E; Barillot I; Duvergé L; Masson I; Abgral R; Santiago Ribeiro MJ; Devillers A; Pallardy A; Fleury V; Mahé MA; De Crevoisier R; Hatt M; Schick U
    J Nucl Med; 2020 Jun; 61(6):814-820. PubMed ID: 31732678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of Semiautomatic CT Volumetry in Patients With Stage I Non-Small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy.
    Satoh Y; Motosugi U; Nambu A; Saito A; Onishi H
    J Comput Assist Tomogr; 2016; 40(3):343-50. PubMed ID: 26854414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer: A Primer for Radiologists.
    Febbo JA; Gaddikeri RS; Shah PN
    Radiographics; 2018; 38(5):1312-1336. PubMed ID: 30074857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Prospective Study of Magnetic Resonance Imaging Assessment of Post-radiation Changes Following Stereotactic Body Radiation Therapy for Non-small Cell Lung Cancer.
    Munoz-Schuffenegger P; Kandel S; Alibhai Z; Hope A; Bezjak A; Sun A; Simeonov A; Cho BCJ; Giuliani M
    Clin Oncol (R Coll Radiol); 2019 Oct; 31(10):720-727. PubMed ID: 31176537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic radiotherapy using tomotherapy for early-stage non-small cell lung carcinoma: analysis of intrafraction tumour motion.
    Boggs DH; Feigenberg S; Walter R; Wissing D; Patel B; Wu T; Rosen L
    J Med Imaging Radiat Oncol; 2014 Dec; 58(6):706-13. PubMed ID: 24767098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeat stereotactic body radiation therapy (SBRT) for salvage of isolated local recurrence after definitive lung SBRT.
    Kennedy WR; Gabani P; Nikitas J; Robinson CG; Bradley JD; Roach MC
    Radiother Oncol; 2020 Jan; 142():230-235. PubMed ID: 31481272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.